Peters MG - Search Results

1

Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.

Lo Re V 3rd, Newcomb CW, Carbonari DM, Roy JA, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Hull M, Gill J, Sterling TR, Kostman JR, Peters MG, Moore RD, Klein MB, Kim HN; North American AIDS Cohort Collaboration on Research and Design of IeDEA. Lo Re V 3rd, et al. Among authors: peters mg. J Acquir Immune Defic Syndr. 2019 Sep 1;82(1):71-80. doi: 10.1097/QAI.0000000000002094. J Acquir Immune Defic Syndr. 2019. PMID: 31107304 Free PMC article.

2

Clinical presentation and course of acute hepatitis C infection in HIV-infected patients.

Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, Havlir D, Peters M. Luetkemeyer A, et al. J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):31-6. doi: 10.1097/01.qai.0000191281.77954.27. J Acquir Immune Defic Syndr. 2006. PMID: 16340470 Free PMC article.

3

Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women.

Tsui JI, French AL, Seaberg EC, Augenbraun M, Nowicki M, Peters M, Tien PC. Tsui JI, et al. Clin Infect Dis. 2007 Sep 15;45(6):736-40. doi: 10.1086/520989. Epub 2007 Aug 10. Clin Infect Dis. 2007. PMID: 17712758 Free PMC article.

4

Diagnosis and management of hepatitis B virus and HIV coinfection.

Peters MG. Peters MG. Top HIV Med. 2007 Nov-Dec;15(5):163-6. Top HIV Med. 2007. PMID: 18073452 Free article.

5

End-stage liver disease in HIV disease.

Peters MG. Peters MG. Top HIV Med. 2009 Sep-Oct;17(4):124-8. Top HIV Med. 2009. PMID: 19890184 Free article.

6

Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus.

Mosbruger TL, Duggal P, Goedert JJ, Kirk GD, Hoots WK, Tobler LH, Busch M, Peters MG, Rosen HR, Thomas DL, Thio CL. Mosbruger TL, et al. Among authors: peters mg. J Infect Dis. 2010 May 1;201(9):1371-80. doi: 10.1086/651606. J Infect Dis. 2010. PMID: 20331378 Free PMC article.

7

Adipose tissue and metabolic factors associated with steatosis in HIV/HCV coinfection: histology versus magnetic resonance spectroscopy.

Ghotb A, Noworolski SM, Madden E, Scherzer R, Qayyum A, Pannell J, Ferrell L, Peters M, Tien PC. Ghotb A, et al. J Acquir Immune Defic Syndr. 2010 Oct;55(2):228-31. doi: 10.1097/QAI.0b013e3181e1d963. J Acquir Immune Defic Syndr. 2010. PMID: 20512045 Free PMC article.

8

Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis.

Bhattacharya D, Umbleja T, Carrat F, Chung RT, Peters MG, Torriani F, Andersen J, Currier JS. Bhattacharya D, et al. Among authors: peters mg. J Acquir Immune Defic Syndr. 2010 Oct;55(2):170-5. doi: 10.1097/QAI.0b013e3181e36420. J Acquir Immune Defic Syndr. 2010. PMID: 20622678 Free PMC article.

9

Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).

Sherman KE, Andersen JW, Butt AA, Umbleja T, Alston B, Koziel MJ, Peters MG, Sulkowski M, Goodman ZD, Chung RT; AIDS Clinical Trials Group A5178 Study Team. Sherman KE, et al. Among authors: peters mg. J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):597-605. doi: 10.1097/QAI.0b013e3181f6d916. J Acquir Immune Defic Syndr. 2010. PMID: 20921898 Free PMC article. Clinical Trial.

10

Effects of hepatitis C and HIV on cognition in women: data from the Women's Interagency HIV Study.

Crystal H, Kleyman I, Anastos K, Lazar J, Cohen M, Liu C, Pearce L, Golub E, Valcour V, Ho A, Strickler H, Peters M, Kovacs A, Holman S, Kreek MJ, Manly J. Crystal H, et al. J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):149-54. doi: 10.1097/QAI.0b013e318240566b. J Acquir Immune Defic Syndr. 2012. PMID: 22107817 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

223 results

Search Page